2016
DOI: 10.1016/j.otoeng.2016.04.005
|View full text |Cite
|
Sign up to set email alerts
|

Second Primary Tumours in Head and Neck Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 32 publications
0
7
0
Order By: Relevance
“…There is a large discrepancy between the prevalence of esophageal-SPTs in patients with HNSCC found with Lugol chromoendoscopy screening (15%, 95% CI: [11][12][13][14][15][16][17][18][19] and the prevalence of retrospective non-screening studies (1%-6%). 6,7,[49][50][51][52][53] This was also noted by Wang, Lee, et al 31 This discrepancy could indicate that without an active screening program, esophageal-SPTs are underdiagnosed in patients with HNSCC. 7 Multiple studies state that the occurrence of esophageal-SPTs negatively influences patient survival, especially in patients with advanced esophageal-SPTs.…”
Section: Discussionmentioning
confidence: 90%
See 1 more Smart Citation
“…There is a large discrepancy between the prevalence of esophageal-SPTs in patients with HNSCC found with Lugol chromoendoscopy screening (15%, 95% CI: [11][12][13][14][15][16][17][18][19] and the prevalence of retrospective non-screening studies (1%-6%). 6,7,[49][50][51][52][53] This was also noted by Wang, Lee, et al 31 This discrepancy could indicate that without an active screening program, esophageal-SPTs are underdiagnosed in patients with HNSCC. 7 Multiple studies state that the occurrence of esophageal-SPTs negatively influences patient survival, especially in patients with advanced esophageal-SPTs.…”
Section: Discussionmentioning
confidence: 90%
“…There is a large discrepancy between the prevalence of esophageal‐SPTs in patients with HNSCC found with Lugol chromoendoscopy screening (15%, 95% CI: 11‐19) and the prevalence of retrospective non‐screening studies (1%‐6%) . This was also noted by Wang, Lee, et al This discrepancy could indicate that without an active screening program, esophageal‐SPTs are underdiagnosed in patients with HNSCC .…”
Section: Discussionmentioning
confidence: 95%
“…Especially for the case of extensive and/or numerous lesions, the decision on the location and size of the tissue sample for a representative biopsy is challenging [ 9 , 10 ]. Moreover, missing out on recurrences and relapses (second primary cancer) or redundant biopsies is problematic [ 11 ].…”
Section: Introductionmentioning
confidence: 99%
“…Head and neck cancer (HNC) is the most frequent primitive cancer associated with lung cancer (14,15). It may be synchronous or metachronous.…”
Section: Introductionmentioning
confidence: 99%
“…It may be synchronous or metachronous. The most frequent second malignant tumor among patients previously treated for HNC is lung cancer (14). Swallowing disorders are common after HNC treatment and are reported in up to 88% of patients depending on the tumor location, tumor size, and treatment (16,17).…”
Section: Introductionmentioning
confidence: 99%